Zyntha

Navigating Medulloblastoma,
Together.

Most common malignant brain tumor in children, medulloblastoma represents ~20% of pediatric CNS tumors. This platform was built to make clinical trial information accessible to every patient and caregiver.

0 Studies Tracked
0 Sources Monitored
24/7 Analysis
WHERE WOULD YOU LIKE TO START?

Everything you need, in one place

Tools and information for everyone navigating cancer — from diagnosis guides to the latest research.

Understanding Medulloblastoma

A plain-language guide to medulloblastomas, treatments, and what to expect.

Read the Medulloblastoma Guide
Research and Publications

Curated trials, molecular data, and research trends for medulloblastoma.

Browse Publications
Find Clinical Trials

Explore active trials by condition, location, and treatment type.

Search Trials
HOW WE WORK

How we keep you informed

We monitor over 2,500 global medical sources 24/7, analyze new studies as they emerge, and organize everything by clinical significance. Complex research is translated into plain language, so patients and caregivers can find what matters most — without the noise.

1
We Monitor

We continuously scan ClinicalTrials.gov, PubMed, FDA, and 2,500+ medical sources for new medulloblastoma-relevant research.

2
We Analyze

Every study is classified by WHO grading criteria, scored for relevance, and enriched with molecular markers and treatment data.

3
You Discover

Browse an intelligence dashboard, explore active clinical trials, or read a curated newsletter — all in plain language.

WHY ZYNTHA

The information exists. Now it's yours.

We use technology to accelerate clinical trials efficiently, bring new treatments to patients faster, and work toward improving outcomes for every medulloblastoma patient.

WHY THIS PLATFORM

What Makes This Different

Unlike traditional clinical trial databases:

Written in Plain Language

Every study, trial, and article is summarized so that patients and families can actually understand it — no medical degree required.

Updated Continuously

We run 24/7, scanning 2,500+ sources. New trials and publications appear here within hours — not weeks or months.

Designed for Medulloblastoma

Built specifically for the medulloblastoma community. Every feature — from WHO grading to subtype filters — speaks your language.

TRUSTED SOURCES

Sourced from the world's leading institutions

All content comes from peer-reviewed medical journals, verified trial registries, and top cancer research centers.

ClinicalTrials.gov PubMed The Lancet Oncology Nature Medicine FDA NCI Neuro-Oncology ASCO MD Anderson Dana-Farber Memorial Sloan Kettering JAMA +108 more

Every article is scored for medulloblastoma relevance, classified by WHO grading criteria, and summarized in patient-friendly language before it reaches you.

We are not medical professionals. This platform is for educational and research purposes only. Always consult your healthcare team for treatment decisions.